Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New research published in Value in Health gives a warning to policy-makers about potential preference traps related to conditional (innovative) payment schemes

Van de Wetering et al. published their research aiming on assessment of the value of removing previously reimbursable treatment from benefit list in comparison with adding new treatment to the list (Value Health. 2017 Jan;20(1):118-125).

Both general public and policy-makers preferred previously reimbursable treatments. It means that ending reimbursement is more difficult than starting reimbursement. Authors advice to consider this effect before engaging into conditional reimbursement schemes.

Read article in Value in Health here.